We're thrilled to announce the Cohort 3 awardees of the Baltimore Life Science Discovery Accelerator (UM-BILD)!
This year's cohort includes groundbreaking projects across our partner institutions — from innovative hemorrhage control technologies to advanced cancer therapies and precision medicine solutions. These researchers represent the best of faculty entrepreneurship, turning discoveries into real-world health care innovations.
Meet the Cohort 3 Awardees:
University of Maryland, Baltimore (UMB) School of Medicine Pilot Project Grants:
- Dr. Joe Rabin: Trans-Esophageal Aortic Blood flow Occlusion (TEABO) to Control Non-Compressible Torso Hemorrhage
- Dr. Paul Buehler: In vivo fiber-optic catheter to measure real-time intra-arterial oxygen saturation & blood pressure
- Dr. Yin Wang: Scale-Up and Dose-Response Evaluation of LNP-Lurbinectedin in Small Cell Lung Cancer
- Dr. Anthony Kim: Commercialization of DART Nanotherapeutics Technology for Fn14-positive Cancers
- Dr. Joe Kao: Assaying Red Blood Cell Quality for Blood Supply Management
University of Maryland, Baltimore County Pilot Project Grants:
- Dr. Zeev Rosenzweig: Multifunctional near-infrared dye-doped polymer dots for near infrared optical imaging and photodynamic therapy
- Dr. Ramana Vinjamuri: An integrated system for management of substance use disorder
Morgan State University Mini-Grants:
- Dr. Mingchao Cai: Iterative decoupling method for poroelastic models that reduce compute times
- Dr. Zheng Li: Using Force-Enhanced Adhesion to Improve Nasal Drug Delivery Efficiency
UM-BILD/MII Joint Projects:
- Ryan Pearson (UMB School of Pharmacy): Preclinical Development of IMPRINT-NP as a Novel Lung Treatment for Severe Asthma
- Hongbing Wang (UMB): New Small Molecule CN06 Boosts Chemotherapy's Anticancer Benefits
UM-BILD/BII Joint Projects:
- Debbie Sahlin (UMB School of Nursing): Advancing Coordinated Care and Emerging Smart Solutions for Disabled Populations (ACCESS-DP)
- Michael Tangrea (Loyola University): Advancing precision medicine through commercialization of micropurification technology
UM-BILD — one of five nationally funded NIH REACH 3.0 Innovation Hubs — helps faculty turn "Benchtop to Bedside," addressing unmet clinical needs through novel technologies.
Ready to innovate? We're now accepting Letters of Intent for Cohort 4: one-year, $75,000 pilot grants + industry mentorship + commercialization training.
Letters of Intent Deadline: Sept. 14, 2026